We assessed HRD, aneuploidy, somatic mutations, copy number variation, and global transcription in paired BRCA1/2 mutation-associated breast and ovarian tumors, focusing on features associated with recurrence. The gene discussed is BRCA1; the disease is ovarian neoplasm.